The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.
Delphine L ChenHoward J HuangDerek E ByersAdrian ShifrenBryan BelikoffJacquelyn T EngleElizabeth ArentsonDebra KempSharon PhillipsDavid E ScherrerHideji FujiwaraKatherine J SpaydFrank J BrooksRichard A PierceMario CastroWarren IsakowPublished in: PloS one (2018)
ClinicalTrials.gov NCT01174056.